ETHZilla Corp
For the period ended Sep 30, 2025. Filed Nov 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 14, 2025
FRMM$2.82-2.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
ETHZILLA CORPORATION,FORMERLY 180 LIFE SCIENCES CORP. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
| September 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| (unaudited) | ||
| Assets | ||
| Current Assets: | ||
| Cash and cash equivalents | $53,309,509 | $4,567,251 |
| Restricted cash equivalents | 505,591,875 | - |
| Prepaid expenses and other current assets | 2,963,219 | 477,507 |
| Current assets of discontinued operations | 83,844 | 96,613 |
| Total Current Assets | 561,948,447 | 5,141,371 |
| Marketable securities | 8,826,571 | - |
| Digital assets | 180,933,721 | - |
| Staking receivables | 257,604,249 | - |
| Other assets of discontinued operations | - | 7,622,041 |
| Total Assets | $1,009,312,988 | $12,763,412 |
| Liabilities and Stockholders’ Equity | ||
| Current Liabilities: | ||
| Accounts payable | $1,198,981 | $305,588 |
| Accounts payable – related parties | 20,246 | 53,380 |
| Accrued expenses | 372,864 | 4,228 |
| Loans payable - current portion | 485,846 | 584 |
| Collateralized loan | 50,000,000 | - |
| Current liabilities of discontinued operations | 3,710,570 | 3,141,105 |
| Total Current Liabilities | 55,788,507 | 3,504,885 |
| Convertible debt, net at fair value | 496,276,461 | - |
| Derivative liabilities | 12,110,655 | - |
| Long term liabilities of discontinued operations | - | 6,616 |
| Total Liabilities | 564,175,623 | 3,511,501 |
| Commitments and contingencies (Note 12) | ||
| Stockholders’ Equity: | ||
| Preferred stock, $0.0001 par value; 5,000,000 shares authorized; (see designations and shares authorized for Series A, Class B, Class C and Class K preferred stock) | ||
| Class B Convertible Preferred stock liability, $0.001 par value, 0 and 1,000,000 shares authorized, issued and outstanding at September 30, 2025 and December 31, 2024, respectively | - | 100 |
| Class C Preferred Stock; 1 share authorized, 0 issued and outstanding at September 30, 2025 and December 31, 2024 | - | - |
| Class K Preferred Stock; 1 share authorized, 0 issued and outstanding at September 30, 2025 and December 31, 2024, respectively | - | - |
| Common stock, $0.0001 par value; 5,000,000,000 shares authorized; 16,667,286 and 317,705 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | 1,666 | 32 |
| Treasury stock 645,043 and 0 shares at September 30, 2025 and December 31, 2024, respectively | (16,121,428) | - |
| Additional paid-in capital | 826,176,044 | 153,692,041 |
| Accumulated other comprehensive income | (2,557,681) | (2,916,918) |
| Accumulated deficit | (362,361,236) | (141,523,344) |
| Total Stockholders’ Equity | 445,137,365 | 9,251,911 |
| Total Liabilities and Stockholders’ Equity | $1,009,312,988 | $12,763,412 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.